Literature DB >> 24267642

Cannabinoid hyperemesis syndrome.

Jose M Roca-Pallín1, Hugo López-Pelayo, Gisela Sugranyes, Maria M Balcells-Oliveró.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24267642      PMCID： PMC6493525          DOI： 10.1111/cns.12207

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN： 1755-5930            Impact factor:   5.243


× No keyword cloud information.
  9 in total

Review 1.  The multiplicity of action of cannabinoids: implications for treating neurodegeneration.

Authors:  Aoife Gowran; Janis Noonan; Veronica A Campbell
Journal:  CNS Neurosci Ther       Date:  2010-09-28       Impact factor: 5.243

Review 2.  Cannabis and endogenous cannabinoid systems.

Authors:  S R Childers; C S Breivogel
Journal:  Drug Alcohol Depend       Date:  1998 Jun-Jul       Impact factor: 4.492

3.  Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy.

Authors:  S E Sallan; N E Zinberg; E Frei
Journal:  N Engl J Med       Date:  1975-10-16       Impact factor: 91.245

4.  The cannabinoid agonist WIN55,212-2 suppresses opioid-induced emesis in ferrets.

Authors:  I I Simoneau; M S Hamza; H P Mata; E M Siegel; T W Vanderah; F Porreca; A Makriyannis; T P Malan
Journal:  Anesthesiology       Date:  2001-05       Impact factor: 7.892

5.  Cannabinoid hyperemesis syndrome: clinical diagnosis of an underrecognised manifestation of chronic cannabis abuse.

Authors:  Siva P Sontineni; Sanjay Chaudhary; Vijaya Sontineni; Stephen J Lanspa
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

6.  Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse.

Authors:  J H Allen; G M de Moore; R Heddle; J C Twartz
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

Review 7.  Cannabidiol: a promising drug for neurodegenerative disorders?

Authors:  Teresa Iuvone; Giuseppe Esposito; Daniele De Filippis; Caterina Scuderi; Luca Steardo
Journal:  CNS Neurosci Ther       Date:  2009       Impact factor: 5.243

8.  Cannabinoid hyperemesis relieved by compulsive bathing.

Authors:  Yoon Hee Chang; Donna M Windish
Journal:  Mayo Clin Proc       Date:  2009       Impact factor: 7.616

Review 9.  Cyclic vomiting syndrome in adults.

Authors:  T L Abell; K A Adams; R G Boles; A Bousvaros; S K F Chong; D R Fleisher; W L Hasler; P E Hyman; R M Issenman; B U K Li; S L Linder; E A Mayer; R W McCallum; K Olden; H P Parkman; C D Rudolph; Y Taché; S Tarbell; N Vakil
Journal:  Neurogastroenterol Motil       Date:  2008-04       Impact factor: 3.598
  9 in total
  5 in total

Review 1.  Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review.

Authors:  Cecilia J Sorensen; Kristen DeSanto; Laura Borgelt; Kristina T Phillips; Andrew A Monte
Journal:  J Med Toxicol       Date:  2016-12-20

2.  Activating cannabinoid receptor 2 alleviates pathogenesis of experimental autoimmune encephalomyelitis via activation of autophagy and inhibiting NLRP3 inflammasome.

Authors:  Bo-Zong Shao; Wei Wei; Ping Ke; Zhe-Qi Xu; Jv-Xiang Zhou; Chong Liu
Journal:  CNS Neurosci Ther       Date:  2014-12       Impact factor: 5.243

3.  Cannabinoid hyperemesis syndrome.

Authors:  Jai D Parekh; Susan E Wozniak; Kamran Khan; Sudhir K Dutta
Journal:  BMJ Case Rep       Date:  2016-01-20

Review 4.  Cannabinoid Hyperemesis Syndrome: A Review of Potential Mechanisms.

Authors:  Marieka V DeVuono; Linda A Parker
Journal:  Cannabis Cannabinoid Res       Date:  2020-06-05

5.  Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome.

Authors:  Thangam Venkatesan; David J Levinthal; B U K Li; Sally E Tarbell; Kathleen A Adams; Robert M Issenman; Irene Sarosiek; Safwan S Jaradeh; Ravi N Sharaf; Shahnaz Sultan; Christopher D Stave; Andrew A Monte; William L Hasler
Journal:  Neurogastroenterol Motil       Date:  2019-06       Impact factor: 3.598
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.